CAPITAL Drug Patent Profile
✉ Email this page to a colleague
When do Capital patents expire, and what generic alternatives are available?
Capital is a drug marketed by Actavis Mid Atlantic, Valeant Pharms Llc, Carnrick, and Loreal Usa. and is included in four NDAs.
The generic ingredient in CAPITAL is avobenzone; ecamsule; octocrylene. There are two drug master file entries for this compound. Additional details are available on the avobenzone; ecamsule; octocrylene profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CAPITAL?
- What are the global sales for CAPITAL?
- What is Average Wholesale Price for CAPITAL?
Summary for CAPITAL
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| DailyMed Link: | CAPITAL at DailyMed |
US Patents and Regulatory Information for CAPITAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Mid Atlantic | CAPITAL AND CODEINE | acetaminophen; codeine phosphate | SUSPENSION;ORAL | 085883-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Loreal Usa | CAPITAL SOLEIL 15 | avobenzone; ecamsule; octocrylene | CREAM;TOPICAL | 021501-001 | Oct 2, 2006 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Valeant Pharms Llc | CAPITAL AND CODEINE | acetaminophen; codeine phosphate | SUSPENSION;ORAL | 086024-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Carnrick | CAPITAL AND CODEINE | acetaminophen; codeine phosphate | TABLET;ORAL | 083643-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
